TVM Life Science Ventures VI GmbH & Co KG Insider Trading
Get free email notifications about insider trading for TVM Life Science Ventures VI GmbH & Co KG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TVM Life Science Ventures VI GmbH & Co KG. TVM Life Science Ventures VI GmbH & Co KG is a Director in Acer Therapeutics Inc. ($OPXA) and a Director in CONCERT PHARMACEUTICALS, INC. ($CNCE) and a 10% Owner in PROTEON THERAPEUTICS INC ($PRTO).
Address: C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 80333Germany
Companies in which TVM Life Science Ventures VI GmbH & Co KG is an Insider
Acer Therapeutics Inc.
Trading Symbol: ACERIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TVM Life Science Ventures VI GmbH & Co KG: Director
Holdings: 725,844 shares
Current Value: $740,361
Latest Transaction: Jan 12 2018
$ACER Market Capitalization: $7.21M
$ACER Previous Close: $1.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CONCERT PHARMACEUTICALS, INC.
Trading Symbol: CNCEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TVM Life Science Ventures VI GmbH & Co KG: Director
Holdings: 378,703 shares
Current Value: $3,389,392
Latest Transaction: Feb 20 2014
$CNCE Market Capitalization: $197.12M
$CNCE Previous Close: $8.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protara Therapeutics, Inc.
Trading Symbol: TARAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of TVM Life Science Ventures VI GmbH & Co KG: 10% Owner
Holdings: 1,943,059 shares
Current Value: $3,788,965
Latest Transaction: Jun 26 2017
$TARA Market Capitalization: $31.94M
$TARA Previous Close: $1.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of TVM Life Science Ventures VI GmbH & Co KG
Sentiment: All, ACER, CNCE, TARA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 12 2018 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 12.00 | 250,000 | 3,000,000 | 1,422,709 | 1.2 M to 1.4 M (+21.32 %) |
Jan 12 2018 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 12.00 | 21,271 | 255,252 | 248,756 | 227.5 K to 248.8 K (+9.35 %) |
Jan 12 2018 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 12.00 | 62,062 | 744,744 | 725,844 | 663.8 K to 725.8 K (+9.35 %) |
Sep 27 2017 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | J | 0.00 | 1,172,709 | 0 | 1,172,709 | 0 to 1.2 M |
Sep 27 2017 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | J | 0.00 | 227,485 | 0 | 227,485 | 0 to 227.5 K |
Sep 27 2017 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | J | 0.00 | 663,782 | 0 | 663,782 | 0 to 663.8 K |
Jun 26 2017 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | P | 0.99 | 128 | 127 | 500 |
View all TVM Life Science Ventures VI GmbH & Co KG insider transactions.